Trial Profile
Oral Azacitidine (CC-486) Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Feb 2024
Price :
$35
*
At a glance
- Drugs Azacitidine (Primary) ; Carboplatin; Etoposide; Ifosfamide; Rituximab
- Indications B-cell lymphoma; Burkitt's lymphoma; Diffuse large B cell lymphoma; Follicular lymphoma
- Focus Adverse reactions
- 31 Jan 2024 Status changed from active, no longer recruiting to completed.
- 26 Sep 2023 Planned End Date changed from 30 Nov 2023 to 31 Dec 2023.
- 25 Jul 2023 Planned End Date changed from 30 Sep 2023 to 30 Nov 2023.